Mesothelioma Experts and Authorities
Public profiles of the physicians, surgeons, researchers, and trial attorneys whose work informs MesoWatch's medical and legal coverage. Each profile collects publicly available information about that authority's role, institutional affiliations, and contributions to mesothelioma research, treatment, or litigation.
Medical Authorities
Thoracic surgeons, medical oncologists, immunotherapy researchers, peritoneal-disease specialists, and mesothelioma genetics researchers whose published work shapes the standard of care.
Dr. Raja M. Flores , MD
Chairman, Department of Thoracic Surgery
Mount Sinai Health System
Pleurectomy/Decortication · Extrapleural Pneumonectomy · VATS Lobectomy
Dr. Robert B. Cameron , MD
Professor of Cardiothoracic Surgery
UCLA Health / David Geffen School of Medicine
Pleurectomy/Decortication · Lung-Sparing Surgery · VATS
Dr. Raphael Bueno , MD
Chief, Division of Thoracic Surgery
Brigham and Women's Hospital / Dana-Farber Cancer Institute
Robotic Thoracic Surgery · Genomic Biomarkers · Gene Ratio Technique
Dr. Valerie W. Rusch , MD, FACS
Miner Family Chair for Intrathoracic Cancers
Memorial Sloan Kettering Cancer Center
Thoracic Oncology · TNM Staging System · Mesothelioma Guidelines
Dr. Harvey I. Pass , MD
Stephen E. Banner Professor of Thoracic Oncology
NYU Grossman School of Medicine
Mesothelioma Biomarkers · Early Detection · Osteopontin Discovery
Dr. Hedy Lee Kindler , MD
Director, Mesothelioma Program
University of Chicago Medicine
Chemotherapy · Pemetrexed Clinical Trials · Immunotherapy Combinations
Dr. Anne S. Tsao , MD, MBA
Vice President for Academic Affairs
MD Anderson Cancer Center
Thoracic Medical Oncology · Chemo-Immunotherapy Sequencing · Gene Therapy Research
Dr. Marjorie G. Zauderer , MD
Medical Oncologist
Memorial Sloan Kettering Cancer Center
Thoracic Oncology · Immunotherapy · Targeted Therapy
Dr. Raffit Hassan , MD
Senior Investigator
National Cancer Institute (NCI)
Mesothelin-Targeted Therapies · CAR-T Cell Research · Immunotoxins
Dr. Dean A. Fennell , MD, PhD
Professor of Thoracic Medical Oncology
University of Leicester
Checkpoint Inhibitors · MiST Trial · CONFIRM Trial
Dr. Paul H. Sugarbaker , MD, FACS, FRCS
Chair, Peritoneal Surface Oncology Group International (PSOGI)
Retired (formerly Washington Cancer Institute)
HIPEC Inventor · Cytoreductive Surgery · Peritoneal Surface Malignancies
Dr. Isabelle Opitz , MD
Thoracic Surgeon
University Hospital Zurich
HIPEC · Peritoneal Mesothelioma · European Guidelines
Dr. Michele Carbone , MD, PhD
Director, Thoracic Oncology
University of Hawaii Cancer Center
BAP1 Gene Mutations · Mesothelioma Genetics · Erionite Research
Dr. Jacqueline Moline , MD, MSc
Chair, Occupational Medicine, Epidemiology and Prevention
Northwell Health / Zucker School of Medicine at Hofstra
Occupational Medicine · Asbestos Exposure · Talc-Mesothelioma Link
Dr. Arthur L. Frank , MD, PhD
Professor Emeritus, Environmental and Occupational Health
Drexel University Dornsife School of Public Health
Occupational Medicine · Global Asbestos Ban Advocacy · Exposure Studies
Dr. Philip J. Landrigan , MD, MSc
Director, Program for Global Public Health and the Common Good
Boston College / Schiller Institute
Environmental Health · Children's Environmental Health · Occupational Disease
Legal Contributors
Trial attorneys with significant mesothelioma case experience who have contributed published commentary, interviews, and case-specific perspective to MesoWatch.
About These Profiles
The authorities profiled here are not employees, paid consultants, or contracted reviewers of MesoWatch. They are public figures in mesothelioma medicine and law whose published research, clinical leadership, courtroom advocacy, and institutional affiliations are part of the standard reference base for serious mesothelioma reporting. Where a MesoWatch article reflects findings, statements, or case outcomes from one of these authorities, the underlying primary source is linked in the article's Sources section.
For corrections, takedown requests, or questions about how an authority is referenced on this site, contact [email protected].